![Richard Buller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 829 950 $ al 31/08/2026
Richard E.
Buller is currently an Independent Director at Celcuity, Inc. since 2019.
Formerly, Dr. Buller was an Independent Director at Rebus Holdings, Inc. from 2016 to 2018.
Dr. Buller served as Director-Oncology Medicine Development Center at GSK Plc.
From 2009 to 2016, Dr. Buller was VP & Head-Clinical Development Oncology at Pfizer Inc. Dr. Buller was Vice President-Translational Medicine at Exelixis, Inc. Dr. Buller was Professor-Gynecologic Oncology at the University of Iowa.
Dr. Buller completed undergraduate studies at the University of California, Los Angeles and earned a doctorate from Baylor College of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELCUITY INC. 0,02 % | 10/06/2026 | 9.319 ( 0,02 % ) | 829 950 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CELCUITY INC. | Director/Miembro de la Junta | 03/12/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| INSPYR THERAPEUTICS, INC. | Director/Miembro de la Junta | 09/02/2018 |
| PFIZER INC. | Corporate Officer/Principal | 01/07/2016 |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Rebus Holdings, Inc.
 Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celcuity, Inc.
 Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
